Harvard Business Review

NOVEMBER 24, 2016

This is particularly true for the marketing department, which is changing at such a break-neck pace that marketing success now depends heavily on support from HR to identify and train new skillsets. On the flip side, success in HR could use a major assist from marketing, or at least HR professionals who think like marketers.

Marketing 8

Marketing Content Pharmaceuticals PR 8

Harvard Business Review

MAY 20, 2014

financial services sector went from 13,000 of independent banks to half that number, while the top ten banks grew from 20% market share to 60%. As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. In the guitar business , too.

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Trends 11

Harvard Business Review

NOVEMBER 19, 2018

If you notice that your best-performing teams are also your most diverse, that may be interesting. For example, Point Nine Capital uses a linear model to sort potential startup opportunities based on variables representing the quality of the team and the technology. Instead, you want to combine diverse models.

Construction 12

Construction Venture Capitalist Price Guidelines 12

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

MARCH 8, 2011

In a world with severe healthcare resource constraints, mobile digital technology can be a major " force multiplier." In this respect, health care is no different from other economic sectors that have gained enormous efficiencies and improved outcomes through the use of modern information and communications technologies (ICT).

Wireless 15

Wireless Health Care Pharmaceuticals Business Model 15

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. Sponsored by DXC Technology.

Innovation 13

Innovation Productivity Products Venture Capitalist 13

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. On the innovation front, the opportunities are more diverse, but equally powerful. Innovations Are Changing The Way We Design Products.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

NOVEMBER 8, 2017

The health care system in the United States, with its technological prowess and massive infrastructure, often serves as a reference point for rapidly developing economies around the world while they build their own medical systems. Over the same period, pharmaceutical exports have doubled. Insight Center. Transforming Health Care.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Information & technology Operations Organizational culture Product development'

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

OCTOBER 26, 2015

A recent USC study shows that across multiple and diverse markets, industries are 25% more likely to be “highly concentrated” than they were 20 years ago. Yet at the same time, America’s largest companies are more than twice as likely to lose market share than in 1980. corporate consolidation.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

MAY 1, 2013

While currently crippled by inadequate infrastructure in many countries, low- and middle-income countries will be the fastest-growing markets for pharmaceuticals and medical devices over the next decade. What can the health care industry do to help fight disease, while still maintaining its commitments to shareholders? Redefine ROI.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

OCTOBER 21, 2013

I found myself reflecting on this recently while speaking with two business leaders in one of the world’s great pharmaceutical companies. Strength in Diverse, Collaborative Teams. These firms lacked diverse, highly collaborative leadership teams. It’s a tough challenge.

Drucker 8

Drucker Diversity Pharmaceuticals Uncertainty 8

Harvard Business Review

FEBRUARY 2, 2015

This is the kind of technology—and the type of firm—that will make renewable energy more efficient and more cost-effective. Indeed, in a world where globalization and rapid technological changes are the norm, manufacturing, high-tech development, and innovation clearly require a different level of support.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

MARCH 8, 2011

If you can reinforce that focus in every decision you make — from mergers & acquisitions to new product launch to budgeting or cutting costs — it can help you win market share, generate sustainable growth, or even turn around a decline. Are we focused strategically on markets where we can compete effectively?

Merchandising 14

Merchandising Budgeting Pharmaceuticals CEO 14

Harvard Business Review

JULY 16, 2013

Both paths are problematic — neither is particularly transparent or relies on objective measures and given that many boards are stubborn bastions of white masculinity, pursuing the "right" network can be fraught, especially for women and other diverse candidates. We also looked at results by industry and region.

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

MARCH 16, 2015

Enrique Santacana of ABB North America, a power and automation-technology firm, voiced his concern this way: “An overarching issue was the exposure we had as a company,” Santacana explained, “For example, how information was being used or may be used in a way that was not conducive to good business practices.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

JUNE 24, 2015

Managers and other business leaders face a dilemma: with increasingly diverse environments to manage and rising stakes to get it right, how do they identify the most effective approach to business strategy and marshal the right thinking and behaviors to conceive and execute it, supported by the appropriate frameworks and tools?

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67